Abstract
As adults living with CF, we feel deeply concerned about the new possibilities in the field of genetic diagnoses in cases of CF, and are considering how to deal with these new techniques. Up to now genetic advice and diagnosis in the case of CF were reserved for people directly or indirectly affected. For example: The brother of a CF patient wanted to know the risk for his children, or a cousin had her pregnancy prenatally tested. But instead of helping CF families clear up the problematic cases, the heterozygote testing enables experts to search for people with CF by testing a great number of people who have an average probability of being a CF gene carrier.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kruip, S. (1999). Statement on CF-Heterozygote Testing. In: Nippert, I., Neitzel, H., Wolff, G. (eds) The New Genetics: From Research into Health Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58486-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-58486-2_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65920-4
Online ISBN: 978-3-642-58486-2
eBook Packages: Springer Book Archive